As people respond to financial and economic hard times by juggling the cost of necessities like groceries and housing, drugs are sometimes having to wait.
Pfizer said that it had an $894 million deal to end more than 90 percent of personal injury suits brought by people claiming the drugs caused heart attacks, strokes or other harm.
The company posted higher third-quarter sales and earnings despite generic competition for certain medications and it raised its guidance for the year.
The drug maker manipulated the publication of studies to bolster use of its epilepsy drug Neurontin, according to expert witnesses in a lawsuit against the company.
The drug maker manipulated the publication of studies to bolster use of its epilepsy drug Neurontin, according to expert witnesses in a lawsuit against the company.
The drug maker said that a product for treating Alzheimer’s improved cognitive functioning in patients who did not carry a genetic variation called ApoE4.
The drug maker said that a product for treating Alzheimer’s improved cognitive functioning in patients who did not carry a genetic variation called ApoE4.
The F.A.A. said it would no longer permit pilots or air traffic controllers to use the smoking cessation drug Chantix, citing potential side effects that could pose a threat to the safe operation of aircraft.
Johnson & Johnson lost the second round in its trademark dispute against the disaster relief agency when a federal judge in Manhattan threw out most of the case.
A television ad for a heart stent may deceive the public and should be reviewed by federal regulators, according to an article published by a leading medical journal.
A television ad for a heart stent may deceive the public and should be reviewed by federal regulators, according to an article published by a leading medical journal.
A report indicating that Merck used ghostwriters to produce articles in support of its drug Vioxx has galvanized opponents to a proposal that would relax some restrictions on drug promotion.
A report indicating that Merck used ghostwriters to produce articles in support of its drug Vioxx has galvanized opponents to a proposal that would relax some restrictions on drug promotion.
Documents unearthed in lawsuits over the pain drug Vioxx provide a rare, detailed look at the industry practice of ghostwriting medical research studies.
Documents unearthed in lawsuits over the pain drug Vioxx provide a rare, detailed look at the industry practice of ghostwriting medical research studies.
In a victory for the tobacco industry, a federal appeals court threw out on Thursday an $800 billion class-action lawsuit on behalf of smokers who said they had been misled that light cigarettes were safer than regular ones.
Reynolds, whose brands include Camel cigarettes, is attacking the F.D.A. as weak and overextended amid a congressional effort to empower the agency to regulate the tobacco industry.
Concern about the possibility of animal viruses has led to a renewed search for synthetic replacements for certain crucial medicines that are still derived from animal parts.
A judge’s ruling that pares back the federal case against Frederick S. Schiff, former chief financial officer at Bristol-Myers Squibb, has delayed his trial.